With the increasing demand for underwater and implantable medical electronics, a stable and continuous power supply is essential. However, conventional wireless charging methods (such as electromagnetic induction and radio frequency-based charging) used in smartphones and wireless earphones suffer from short transmission distances, low energy transfer efficiency in biological tissues, and electromagnetic interference.

Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.